CenterPoint Q3 2026 Earnings: EPS Rises, 2026 Guidance Raised
CenterPoint Energy reported third-quarter 2026 GAAP net income of $331 million, or $0.50 per diluted share, and non-GAAP EPS of $0.53, both exceeding prior-year figures. Strong growth, rate recovery, and favorable weather offset higher financing expenses and tax comparison headwinds. The company raised its 2026 non-GAAP EPS guidance to $1.90–$1.92, initiated a 2027 outlook of $2.07–$2.09, and expanded its 10-year capital plan to $70.7 billion to support Greater Houston demand. Key investment risks include financing sensitivity, regulatory capital recovery, demand variability, and earnings differences between GAAP and non-GAAP metrics.
CenterPoint Energy (NYSE: CNP) reported third-quarter 2026 GAAP net income of $331 million and diluted EPS of $0.50, compared with $293 million and $0.45 a year earlier; non-GAAP EPS increased to $0.53 from $0.50. Growth and rate recovery, along with favorable weather and usage, more than offset higher financing expenses and the absence of a one-time tax optimization benefit recorded in the prior-year quarter. The company also raised its 2026 non-GAAP EPS guidance and expanded its 10-year capital plan to $70.7 billion.
Core Earnings Data
CenterPoint’s quarterly earnings improved on both GAAP and non-GAAP bases. GAAP net income rose approximately 13%, while non-GAAP income increased approximately 8%; the $23 million difference between GAAP and non-GAAP income primarily reflects temporary emergency electric energy facility impacts and other specified adjustments.
| Metric | Q3 2026 | Q3 2025 | Year-Over-Year Change |
|---|---|---|---|
| GAAP net income | $331 million | $293 million | Approx. +13% |
| GAAP diluted EPS | $0.50 | $0.45 | Approx. +11% |
| Non-GAAP income | $354 million | $328 million | Approx. +8% |
| Non-GAAP diluted EPS | $0.53 | $0.50 | +6% |
Non-GAAP results exclude specified impacts related to ZENS securities, mergers and divestitures, and temporary emergency electric energy facilities removed from the rate-regulated business.
Rate Recovery Outpaced Financing and Tax Comparison Headwinds
The non-GAAP EPS bridge shows that operating and regulatory factors added $0.12 per share compared with Q3 2025, but financing and other items removed $0.09 per share. This produced the net $0.03 increase in quarterly non-GAAP EPS.
- Growth and rate recovery contributed a favorable $0.09 per share.
- Weather and customer usage added $0.03 per share.
- Operations and maintenance expense was flat year over year.
- Higher financing expenses reduced EPS by $0.04, reflecting new debt issuance and equity dilution.
- Other items reduced EPS by $0.05, primarily because the prior-year quarter included a one-time tax optimization benefit.
The result indicates that regulated investment recovery and customer-related growth were sufficient to absorb financing pressure, although the cost of funding remains material to earnings progression.
Capital Plan Expands With Greater Houston Demand
CenterPoint increased its 10-year capital investment plan by $4.0 billion, from $66.7 billion to $70.7 billion. It also accelerated an additional $1.5 billion of investment into 2026 through 2030 in response to customer demand in Greater Houston.
The revised plan supports a projected rate-base compound annual growth rate of more than 14% through 2030. CenterPoint also maintained at least $10 billion of additional potential investment opportunities through 2035, focused on system capacity, reliability, safety, and economic development.
Management characterized the expansion as customer-driven and tied to Greater Houston’s demand pipeline. The larger program increases the importance of timely capital recovery, financing costs, and regulatory execution to the company’s earnings outlook.
Earnings Guidance
CenterPoint raised its 2026 non-GAAP EPS guidance and introduced a range for 2027. It also extended its expectation for annual non-GAAP EPS growth at the mid-to-high end of its 7% to 9% range through 2030.
| Metric | Latest Outlook | Update |
|---|---|---|
| 2026 non-GAAP EPS | $1.90-$1.92 | Raised; midpoint represents nearly 9% growth over 2025 |
| 2027 non-GAAP EPS | $2.07-$2.09 | Initiated; midpoint represents approximately 9% growth over 2026 guidance |
| Annual non-GAAP EPS growth | Mid-to-high end of 7%-9% | Outlook extended through 2030 |
The guidance assumes factors including customer growth and usage, normal weather, capital recovery, tax rates, financing activity, interest rates, and regulatory and judicial outcomes. CenterPoint did not provide a quantitative GAAP reconciliation because future ZENS valuation changes, impairments, and other unusual items cannot be reliably estimated.
Recent Insider Transactions
The supplied insider records show one direct purchase among the 10 latest entries, while the other nine entries were zero-price stock awards. Director Laurie Lee Fitch made the only purchase listed in that group.
| Date | Insider | Role | Transaction | Approx. Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug. 17, 2026 | Laurie Lee Fitch | Director | Direct purchase | 1,000 | $40.70 | $40,700 |
The same source’s separate six-month summary reported zero purchase transactions, which conflicts with the detailed record. The transaction should therefore be interpreted cautiously, and a single purchase does not establish a broader insider view of the company’s outlook.
Risks Investors Need to Watch
- Financing sensitivity: New debt issuance and equity dilution reduced quarterly EPS by $0.04. Financing activity and interest rates are also explicit assumptions underlying the company’s guidance.
- Capital execution and recovery: The $70.7 billion investment plan and projected rate-base growth depend on project execution and the recovery of invested capital through applicable regulatory processes.
- Demand and weather assumptions: Guidance incorporates customer growth, usage, throughput, and normal weather. Results could differ if these variables deviate from the company’s assumptions.
- GAAP and non-GAAP variability: ZENS valuation changes, divestiture-related items, TEEEF impacts, and potential impairments can cause reported GAAP earnings to differ from non-GAAP results.
Summary
CenterPoint’s Q3 2026 earnings improved as growth, rate recovery, weather, and usage outweighed higher financing costs and a tougher tax comparison. The expanded capital plan and raised guidance point to continued reliance on Greater Houston demand and regulated investment growth, while financing expenses, capital recovery, and execution of the larger investment program remain the main areas to monitor.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles










Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.